CTRI/2021/05/033828尚未招募未知
Gynecological cancer surgery following recovery from COVID-19 infection: An Observational study(COSGO) - COSGO
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- one
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •The following patients will be included:
- •-The patients who have recovered from a COVID 19 infection and undergoing elective or emergency gynaecological cancer surgery excluding minor OT procedures done at TMH and ACTREC, Mumbai will be included.
- •-The previous diagnosis of COVID 19 would be based on positive COVID-19 lab test.
- •-Definition of COVID 19 positive: test positive [either the test undergone at Tata Memorial Hospital (TMH) or any centre outside TMH with reports]
- •-Definition of COVID 19 negative : â??Test negativeâ?? at TMH/ACTREC.
- •-Duration from COVID test: When the patient is COVID 19 negative and fit for surgery as per hospital protocol (generally patients undergo surgery 2 to 4 wks when COVID 19 test is negative).
- •-The test is as per recommendations by National task force (ICMR) on COVID 19 during that period. As per the current ICMR advisory on strategy for COVID â?? 19 testing in India (Version VI, dated 04/09/2020), the current recommended tests are RT-PCR or TrueNat or CBNAAT, Rapid Antigen Test (RAT).
- •-Definition of recovery: COVID 19 test negative and considered fit to undergo surgery.
- •The study group would consist of recovered COVID 19 positive patients fit for surgery (Test negative at present, and fit for surgery).They had a past history of COVID 19 positivity ( Test positive at TMH / non-TMH) but currently, they are tested negative at TMH and fit for surgery.
- •The control group would consist of COVID 19 Negative patients( Test negative at TMH/ACTREC) fit for surgery and without any past history of COVID 19 positivity.
- •Consent will be obtained from both the study group and Control group patients included in the study.
排除标准
- •The COVID 19 Positive patients undergoing /undergone surgery(those who were Test positive at the time of surgery) will be excluded from the study.
研究者
相似试验
已完成
不适用
The role of follow-up after gynaecological cancerCancer: GynaecologicalGynaecologicalCancerISRCTN67227760Record Provided by the NHSTCT Register - 2006 Update - Department of Health200
尚未招募
不适用
Enhancing treatment outcomes after gynaecological cancer (ACUMEN For ALL): Using telehealth exercise delivery to promote health after cancer therapyGynaecological cancerCancer - Ovarian and primary peritonealCancer - Cervical (cervix)Cancer - Womb (Uterine or endometrial cancer)Cancer - Other cancer typesACTRN12622000898752The University of Queensland50
招募中
不适用
Enhancing treatment outcomes after gynaecological cancer (ACUMEN): Using exercise to promote health after cancer therapyGynaecological cancerCancer - Ovarian and primary peritonealCancer - Cervical (cervix)Cancer - Womb (Uterine or endometrial cancer)Cancer - Other cancer typesACTRN12621000050853The University of Queensland342
尚未招募
不适用
Does Enhanced Recovery after Surgery protocol (ERAS ) improve patient outcome after surgery on food pipe ( esophagus) for cancerCTRI/2022/02/040588Swami Rama Himalayan university
进行中（未招募）
不适用
Postoperative pain treatment following gynecologic surgery, using different doses of transdermal buprenorphine a double ? blind, randomized study - Transdermal buprenorphine for the treatment of postoperative paiPatients elected for laparotomic hysterectomyMedDRA version: 9.1Level: LLTClassification code 10021151Term: HysterectomyEUCTR2008-003946-28-ITISTITUTO PER L`INFANZIA BURLO GAROFOLO